HRP20180275T1 - Sustav zavoja - Google Patents
Sustav zavoja Download PDFInfo
- Publication number
- HRP20180275T1 HRP20180275T1 HRP20180275TT HRP20180275T HRP20180275T1 HR P20180275 T1 HRP20180275 T1 HR P20180275T1 HR P20180275T T HRP20180275T T HR P20180275TT HR P20180275 T HRP20180275 T HR P20180275T HR P20180275 T1 HRP20180275 T1 HR P20180275T1
- Authority
- HR
- Croatia
- Prior art keywords
- nitrite
- hydrogel
- skin
- ulceration
- wound
- Prior art date
Links
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 claims 7
- 239000000017 hydrogel Substances 0.000 claims 6
- 208000025865 Ulcer Diseases 0.000 claims 5
- -1 hydrogen ions Chemical class 0.000 claims 5
- 230000036269 ulceration Effects 0.000 claims 5
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 claims 3
- 206010052428 Wound Diseases 0.000 claims 3
- 208000027418 Wounds and injury Diseases 0.000 claims 3
- 230000003444 anaesthetic effect Effects 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 3
- 208000028867 ischemia Diseases 0.000 claims 3
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 claims 2
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 claims 2
- 229920001577 copolymer Polymers 0.000 claims 2
- 229960004194 lidocaine Drugs 0.000 claims 2
- 229920000642 polymer Polymers 0.000 claims 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical group [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 claims 2
- 229960002372 tetracaine Drugs 0.000 claims 2
- GKCBAIGFKIBETG-UHFFFAOYSA-N tetracaine Chemical compound CCCCNC1=CC=C(C(=O)OCCN(C)C)C=C1 GKCBAIGFKIBETG-UHFFFAOYSA-N 0.000 claims 2
- ZKMNUMMKYBVTFN-HNNXBMFYSA-N (S)-ropivacaine Chemical compound CCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C ZKMNUMMKYBVTFN-HNNXBMFYSA-N 0.000 claims 1
- LEBVLXFERQHONN-UHFFFAOYSA-N 1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide Chemical compound CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C LEBVLXFERQHONN-UHFFFAOYSA-N 0.000 claims 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims 1
- 206010011985 Decubitus ulcer Diseases 0.000 claims 1
- 208000034693 Laceration Diseases 0.000 claims 1
- 239000004743 Polypropylene Substances 0.000 claims 1
- 208000003782 Raynaud disease Diseases 0.000 claims 1
- 208000012322 Raynaud phenomenon Diseases 0.000 claims 1
- 206010040070 Septic Shock Diseases 0.000 claims 1
- 208000002847 Surgical Wound Diseases 0.000 claims 1
- 238000005299 abrasion Methods 0.000 claims 1
- 229910052783 alkali metal Inorganic materials 0.000 claims 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 claims 1
- 229960005274 benzocaine Drugs 0.000 claims 1
- 229960003150 bupivacaine Drugs 0.000 claims 1
- 239000003638 chemical reducing agent Substances 0.000 claims 1
- 229960003920 cocaine Drugs 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- INWLQCZOYSRPNW-UHFFFAOYSA-N mepivacaine Chemical compound CN1CCCCC1C(=O)NC1=C(C)C=CC=C1C INWLQCZOYSRPNW-UHFFFAOYSA-N 0.000 claims 1
- 229960002409 mepivacaine Drugs 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 229920001155 polypropylene Polymers 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- MVFGUOIZUNYYSO-UHFFFAOYSA-N prilocaine Chemical compound CCCNC(C)C(=O)NC1=CC=CC=C1C MVFGUOIZUNYYSO-UHFFFAOYSA-N 0.000 claims 1
- 229960001807 prilocaine Drugs 0.000 claims 1
- 229960001549 ropivacaine Drugs 0.000 claims 1
- 230000036303 septic shock Effects 0.000 claims 1
- 235000010288 sodium nitrite Nutrition 0.000 claims 1
- 125000003396 thiol group Chemical class [H]S* 0.000 claims 1
- 229940072358 xylocaine Drugs 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/18—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing inorganic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/24—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/26—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/425—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/60—Liquid-swellable gel-forming materials, e.g. super-absorbents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
- A61L2300/114—Nitric oxide, i.e. NO
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/204—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with nitrogen-containing functional groups, e.g. aminoxides, nitriles, guanidines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Materials Engineering (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Polymers & Plastics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Claims (15)
1. Sustav zavoja za kožu koji sadrži:
(i) sloj u kontaktu s kožom koji sadrži nitrit; i
(ii) hidrogel koji sadrži vodikove ione;
naznačen time što sustav zavoja za kožu ne sadrži izvor iona Cu2+, Zn2+ i/ili Fe2+, gdje sustav ne sadrži tiol ili redukcijsko sredstvo; gdje dodatno sloj u kontaktu s kožom koji sadrži nitrit nije hidrogel.
2. Sustav prema patentnom zahtjevu 1, naznačen time što sloj u kontaktu s kožom predstavlja mrežu.
3. Sustav prema patentnom zahtjevu 2, naznačen time što je mreža formirana od polimera.
4. Sustav prema patentnom zahtjevu 3, naznačen time što je polimer polipropilen.
5. Sustav prema bilo kojem od prethodnih patentnih zahtjeva, naznačen time što:
(a) nitrit predstavlja nitrit alkalijskog metala ili nitrit zemnoalkalijskog metala; i/ili
(b) sustav sadrži mnoštvo slojeva u kontaktu s kožom koji sadrže nitrit; i/ili
(c) nitrit je prisutan kao otopina nitrita.
6. Sustav prema patentnom zahtjevu 5 dio (a), naznačen time što nitrit predstavlja natrijev nitrit.
7. Sustav prema bilo kojem od prethodnih patentnih zahtjeva, naznačen time što:
(a) je hidrogel djelomično hidratiziran; i/ili
(b) je hidrogel umrežen; i/ili
(c) je hidrogel kopolimer.
8. Sustav prema patentnom zahtjevu 7 dio (c), naznačen time što je hidrogel kopolimer polisulfonata i akrilne kiseline.
9. Sustav prema bilo kojem od prethodnih patentnih zahtjeva za upotrebu u medicini.
10. Sustav prema bilo kojem od prethodnih patentnih zahtjeva za upotrebu u liječenju stanja povezanog s ishemijom tkiva ili ranom.
11. Sustav za upotrebu prema patentnom zahtjevu 10, naznačen time što:
(a) rana predstavlja ulceraciju; ili
(b) je rana mjesto doniranja kože, kirurška rana, opeklina, laceracija ili abrazija; ili
(c) je stanje povezano s ishemijom tkiva Raynaudov sindrom ili je ishemija tkiva izazvana septičkim šokom.
12. Sustav za upotrebu prema patentnom zahtjevu 11 dio (a), naznačen time što ulceracija predstavlja ulceraciju nogu, dekubitalnu ulceraciju ili dijabetičnu ulceraciju.
13. Sustav prema bilo kojem od patentnih zahtjeva 1 do 8 u kombinaciji s lijekom topivim u vodi za upotrebu u medicini.
14. Sustav prema bilo kojem od patentnih zahtjeva 1 do 8 u kombinaciji s anestetikom za upotrebu u liječenju ili sprečavanju bola.
15. Sustav za upotrebu prema patentnom zahtjevu 14, naznačen time što:
(a) se sustav primjenjuje istovremeno, odvojeno ili uzastopno sa spomenutim anestetikom;
i/ili
(b) je anestetik odabran iz grupe koja se sastoji od lignokaina (lidokaina), ametokaina (tetrakaina), ksilokaina, bupivakaina, prilokaina, ropivakaina, benzokaina, mepivakaina, kokaina ili njihove smjese.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1309091.5A GB201309091D0 (en) | 2013-05-20 | 2013-05-20 | Dressing system |
| EP14726729.8A EP2908872B1 (en) | 2013-05-20 | 2014-05-20 | Dressing system |
| PCT/GB2014/051543 WO2014188174A1 (en) | 2013-05-20 | 2014-05-20 | Dressing system |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20180275T1 true HRP20180275T1 (hr) | 2018-04-20 |
Family
ID=48747064
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20180275TT HRP20180275T1 (hr) | 2013-05-20 | 2018-02-14 | Sustav zavoja |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US9662414B2 (hr) |
| EP (1) | EP2908872B1 (hr) |
| JP (1) | JP6559655B2 (hr) |
| CN (1) | CN105579074B (hr) |
| AU (1) | AU2014270115B2 (hr) |
| DK (1) | DK2908872T3 (hr) |
| ES (1) | ES2661643T3 (hr) |
| GB (1) | GB201309091D0 (hr) |
| HR (1) | HRP20180275T1 (hr) |
| HU (1) | HUE038361T2 (hr) |
| LT (1) | LT2908872T (hr) |
| NO (1) | NO2908872T3 (hr) |
| PL (1) | PL2908872T3 (hr) |
| PT (1) | PT2908872T (hr) |
| RS (1) | RS56954B1 (hr) |
| SA (1) | SA515370167B1 (hr) |
| WO (1) | WO2014188174A1 (hr) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201309092D0 (en) * | 2013-05-20 | 2013-07-03 | Edixomed Ltd | Transdermal delivery system |
| GB201420761D0 (en) | 2014-11-21 | 2015-01-07 | Edixomed Ltd And First Water Ltd | Dressing system |
| GB201520990D0 (en) | 2015-11-27 | 2016-01-13 | Edixomed Ltd | Dressing system |
| US11506658B2 (en) | 2019-04-24 | 2022-11-22 | Progenitec, Inc. | System for analysis of body fluids and wound-associated biomolecules |
| BR112021023832A8 (pt) | 2019-06-04 | 2023-02-28 | Thirty Holdings Ltd | Métodos e composições para geração de óxido nítrico e usos dos mesmos |
| AU2020286987A1 (en) | 2019-06-04 | 2021-12-16 | Thirty Respiratory Limited | Methods and compositions for generating nitric oxide and uses thereof to deliver nitric oxide via the respiratory tract |
| KR20220104141A (ko) * | 2019-06-12 | 2022-07-26 | 사노타이즈 리서치 앤드 디벨롭먼트 코퍼레이션 | 약물 수용 장치 및 관련 조성물 |
| CN115361976A (zh) | 2020-04-02 | 2022-11-18 | T.J.史密夫及内修有限公司 | 伤口敷料控制和活化 |
| GB202004868D0 (en) * | 2020-04-02 | 2020-05-20 | Smith & Nephew | Wound care compositions and methods of preparation thereof |
| BR112022021436A2 (pt) | 2020-04-23 | 2023-01-17 | Thirty Respiratory Ltd | Métodos e composições para tratamento e combate da tuberculose |
| EP4138795A1 (en) | 2020-04-23 | 2023-03-01 | Thirty Respiratory Limited | Nitric oxide or nitric oxide releasing compositions for use in treating sars-cov and sars-cov-2 |
| CN113101053A (zh) * | 2021-03-30 | 2021-07-13 | 上海健康医学院 | 一种可释放一氧化氮的创伤敷料 |
| DE112022003204A5 (de) | 2021-06-23 | 2024-04-25 | Beiersdorf Aktiengesellschaft | Hautabdeckung, zur Erhöhung der NO Konzentration in der Haut |
| GB202114294D0 (en) * | 2021-10-06 | 2021-11-17 | Smith & Nephew | Wound dressing apparatuses and methods for nitric oxide delivery |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1100556B1 (en) * | 1998-07-31 | 2003-11-12 | First Water Limited | Bioadhesive compositions and biomedical electrodes containing them |
| GB9905425D0 (en) * | 1999-03-09 | 1999-05-05 | Queen Mary & Westfield College | Pharmaceutical composition |
| GB0021317D0 (en) | 2000-08-30 | 2000-10-18 | Queen Mary & Westfield College | Transdermal pharmaceutical delivery composition |
| CA2323382C (en) * | 2000-10-17 | 2004-04-13 | Pharma Mag Inc. | Wound dressing |
| GB0715556D0 (en) * | 2007-08-09 | 2007-09-19 | Insense Ltd | Improvements relating to skin dressings |
| GB0715554D0 (en) | 2007-08-09 | 2007-09-19 | Insense Ltd | Improvements relating to skin dressings |
| US20100055161A1 (en) * | 2008-08-27 | 2010-03-04 | Dong June Ahn | Hydrogel face mask for delivering skin care agents |
| ES2675879T3 (es) * | 2009-12-22 | 2018-07-13 | Rigshospitalet, Copenhagen University Hospital | Productos para el cuidado de heridas |
-
2013
- 2013-05-20 GB GBGB1309091.5A patent/GB201309091D0/en not_active Ceased
-
2014
- 2014-05-20 LT LTEP14726729.8T patent/LT2908872T/lt unknown
- 2014-05-20 PT PT147267298T patent/PT2908872T/pt unknown
- 2014-05-20 CN CN201480029018.2A patent/CN105579074B/zh active Active
- 2014-05-20 ES ES14726729.8T patent/ES2661643T3/es active Active
- 2014-05-20 NO NO14726729A patent/NO2908872T3/no unknown
- 2014-05-20 US US14/892,214 patent/US9662414B2/en active Active
- 2014-05-20 RS RS20180181A patent/RS56954B1/sr unknown
- 2014-05-20 WO PCT/GB2014/051543 patent/WO2014188174A1/en active Application Filing
- 2014-05-20 EP EP14726729.8A patent/EP2908872B1/en active Active
- 2014-05-20 DK DK14726729.8T patent/DK2908872T3/en active
- 2014-05-20 HU HUE14726729A patent/HUE038361T2/hu unknown
- 2014-05-20 PL PL14726729T patent/PL2908872T3/pl unknown
- 2014-05-20 JP JP2016514477A patent/JP6559655B2/ja active Active
- 2014-05-20 AU AU2014270115A patent/AU2014270115B2/en active Active
-
2015
- 2015-11-19 SA SA515370167A patent/SA515370167B1/ar unknown
-
2018
- 2018-02-14 HR HRP20180275TT patent/HRP20180275T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN105579074A (zh) | 2016-05-11 |
| JP6559655B2 (ja) | 2019-08-14 |
| AU2014270115A1 (en) | 2015-12-03 |
| US20160082142A1 (en) | 2016-03-24 |
| AU2014270115B2 (en) | 2017-12-21 |
| RS56954B1 (sr) | 2018-05-31 |
| LT2908872T (lt) | 2018-03-12 |
| WO2014188174A1 (en) | 2014-11-27 |
| SA515370167B1 (ar) | 2017-10-05 |
| PT2908872T (pt) | 2018-03-08 |
| NO2908872T3 (hr) | 2018-04-14 |
| PL2908872T3 (pl) | 2018-06-29 |
| ES2661643T3 (es) | 2018-04-02 |
| US9662414B2 (en) | 2017-05-30 |
| EP2908872B1 (en) | 2017-11-15 |
| HUE038361T2 (hu) | 2018-10-29 |
| DK2908872T3 (en) | 2018-02-26 |
| CN105579074B (zh) | 2018-04-10 |
| EP2908872A1 (en) | 2015-08-26 |
| JP2016522829A (ja) | 2016-08-04 |
| GB201309091D0 (en) | 2013-07-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20180275T1 (hr) | Sustav zavoja | |
| HRP20180079T1 (hr) | Transdermalni sustav za isporuku | |
| JP2016522829A5 (hr) | ||
| JP2016518458A5 (hr) | ||
| CL2012003470A1 (es) | Una composicion solida que comprende 1) un compuesto inhibidor del hcv de formula definida, o una sal farmaceuticamente aceptable de este, en una forma amorfa, 2) un polimero hidrofilico, y opcionalmente 3) un agente tensoactivo; su proceso de preparacion, util para tratar una infeccion del hcv. | |
| BR112013031464A2 (pt) | métodos e membros de contato com a ferida | |
| EA200601776A1 (ru) | Метадоновые композиции местного действия и способы их применения | |
| ATE551996T1 (de) | Behandlung oder prävention von diabetes mit cannabidiol | |
| BR112012006891A2 (pt) | formulação de hydrogel compreendendo uma solução aquosa com potencial oxidativo redutivo | |
| MX2015012879A (es) | Formulaciones combinadas de neosaxitoxina para una anestesia local prolongada. | |
| EA201300704A1 (ru) | Трансдермальная терапевтическая система для введения активного вещества | |
| ATE447948T1 (de) | Verwendung von benzokondensierten heterocyclischen sulfamid-derivaten zur behandlung von schmerzen | |
| BR112015025805A2 (pt) | compostos de ligação de nh3 e métodos para inibir o transporte de fosfato | |
| ATE462438T1 (de) | Verwendung von carrageenan zur behandlung von rhinovirus-infektionen | |
| MX2013004873A (es) | Metodos y composiciones para tratar diarrea asociada con vih. | |
| EA201001324A1 (ru) | Гель, обладающий противовоспалительным и противоаллергическим действием | |
| NZ631279A (en) | Method for treatment of labor arrest | |
| RU2009122281A (ru) | Средство для лечения заболеваний в ветеринарии на основе соли фосфония | |
| RU2011136311A (ru) | Фармацевтические композиции для обезвоживания, атрофии и удаления патологических тканей | |
| CL2008001282A1 (es) | Composicion farmaceutica con actividad antimicrobiana que comprende un aminoacidos n halogenado y un agente antiinflamatorio; uso para prevenir o tratar una infeccion de tejidos, donde dicho tejido es ocular, nasal, seno nasal o dermico o una infeccion respiratoria. | |
| MY169911A (en) | Thermally conductive, metal-based bandages to aid in medical healing and methods of use | |
| Augustine et al. | Pseudomonas aeruginosa wound infections: a critical appraisal of topical antiseptics | |
| CN108210989A (zh) | 一种液体创可贴 | |
| BR112015015938A2 (pt) | uso de cloridrato de fenilefrina e paracetamol, medicamento, método de tratamento de congestão das mucosas do trato respiratório superior em um humano adulto | |
| WO2014201083A3 (en) | Phenoxybenzamine transdermal composition |